Your browser doesn't support javascript.
loading
Characterizing the protonation states of the catalytic residues in apo and substrate-bound human T-cell leukemia virus type 1 protease.
Ma, Shuhua; Vogt, Kimberly A; Petrillo, Natalie; Ruhoff, Alyce J.
Afiliação
  • Ma S; Department of Chemistry, Fisher College of Science and Mathematics, Towson University, 8000 York Road, Towson, MD 21252, USA. Electronic address: sma@towson.edu.
  • Vogt KA; Department of Chemistry, Fisher College of Science and Mathematics, Towson University, 8000 York Road, Towson, MD 21252, USA.
  • Petrillo N; Department of Chemistry, Fisher College of Science and Mathematics, Towson University, 8000 York Road, Towson, MD 21252, USA.
  • Ruhoff AJ; Department of Chemistry, University of Wisconsin - Stevens Point, 2001 Fourth Avenue, Stevens Point, WI 54481, USA​
Comput Biol Chem ; 56: 61-70, 2015 Jun.
Article em En | MEDLINE | ID: mdl-25889320
ABSTRACT
Human T-cell leukemia virus type 1 (HTLV-1) protease is an attractive target when developing inhibitors to treat HTLV-1 associated diseases. To study the catalytic mechanism and design novel HTLV-1 protease inhibitors, the protonation states of the two catalytic aspartic acid residues must be determined. Free energy simulations have been conducted to study the proton transfer reaction between the catalytic residues of HTLV-1 protease using a combined quantum mechanical and molecular mechanical (QM/MM) molecular dynamics simulation. The free energy profiles for the reaction in the apo-enzyme and in an enzyme - substrate complex have been obtained. In the apo-enzyme, the two catalytic residues are chemically equivalent and are expected to be both unprotonated. Upon substrate binding, the catalytic residues of HTLV-1 protease evolve to a singly protonated state, in which the OD1 of Asp32 is protonated and forms a hydrogen bond with the OD1 of Asp32', which is unprotonated. The HTLV-1 protease-substrate complex structure obtained from this simulation can serve as the Michaelis complex structure for further mechanistic studies of HTLV-1 protease while providing a receptor structure with the correct protonation states for the active site residues toward the design of novel HTLV-1 protease inhibitors through virtual screening.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus Linfotrópico T Tipo 1 Humano / Infecções por HTLV-I / Ácido Aspártico Endopeptidases Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus Linfotrópico T Tipo 1 Humano / Infecções por HTLV-I / Ácido Aspártico Endopeptidases Idioma: En Ano de publicação: 2015 Tipo de documento: Article